# Daclizumab Japanese PK Study

> **NCT01929746** · PHASE1 · COMPLETED · sponsor: **Biogen** · enrollment: 56 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** BIIB019 subcutaneous injection

## Key facts

- **NCT ID:** NCT01929746
- **Lead sponsor:** Biogen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-03
- **Final completion:** 2014-03
- **Target enrollment:** 56 (ACTUAL)
- **Last updated:** 2014-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01929746

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01929746, "Daclizumab Japanese PK Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01929746. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*